Jan Chu
Impact in
-
- CAR-T cell therapy research
-
- Innovation and Socioeconomic Development
Papers in
- Oncology 5
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 1
-
- COVID-19 Clinical Research Studies 1
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Robert Chiesa (4 shared papers)Rebecca Thomas (3 shared papers)Hong Zhan (2 shared papers)David O’Connor (3 shared papers)Soragia Athina Gkazi (2 shared papers)Christos Georgiadis (4 shared papers)Kimberly Gilmour (5 shared papers)Annie Etuk (3 shared papers)
- Partner nations
- United Kingdom
In The Last Decade
Jan Chu
4 papers receiving 219 citations
Jan Chu's Hit Papers
Peers
Comparison fields: 5 of 32
- Oncology 155
- Business and International Management 11
- Genetics 68
- Molecular Biology 119
- Immunology 34
Countries citing papers authored by Jan Chu
This map shows the geographic impact of Jan Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Chu more than expected).
Fields of papers citing papers by Jan Chu
This network shows the impact of papers produced by Jan Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Chu. The network helps show where Jan Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia Hit paper breakdown → | 2023 | 188 |
| 2 | 2022 | 31 | |
| 3 | 2021 | 4 | |
| 4 | 2025 | 1 | |
| 5 | 2022 | 0 | |
| 6 | 2025 | 0 |
About Jan Chu
Jan Chu is a scholar working on Oncology, Infectious Diseases, Molecular Biology, Physiology and Genetics, having authored 6 papers that have together received 224 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), COVID-19 Clinical Research Studies (1 paper), Nanowire Synthesis and Applications (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Virus-based gene therapy research (1 paper), CRISPR and Genetic Engineering (1 paper) and Biomedical Ethics and Regulation (1 paper). The work is most often cited by research in Oncology (155 citations), Business and International Management (11 citations), Genetics (68 citations), Molecular Biology (119 citations) and Immunology (34 citations). Jan Chu has collaborated with scholars based in United Kingdom. Frequent co-authors include Robert Chiesa, Rebecca Thomas, Hong Zhan, David O’Connor, Soragia Athina Gkazi, Christos Georgiadis, Kimberly Gilmour, Annie Etuk, Giorgio Ottaviano and Farhatullah Syed. Their work appears in journals such as New England Journal of Medicine, Blood and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.